Actelion Ltd (ALIOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALIOF | BIIB | ALNY | ||
| Company | Actelion Ltd | Biogen Inc | Alnylam Pharmaceuticals | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 278.3400 | 203.34 | 208.04 | ||
| High | 280.0000 | 203.85 | 220.49 | ||
| Low | 278.3400 | 199.58 | 208.04 | ||
| Last | 278.5000 | 201.82 | 220.33 | ||
| Change | unch | -1.13 | +14.81 | ||
| Percent Change | unch | -0.56% | +7.21% | ||
| Volume | 100 | 940,800 | 3,399,800 | ||
| 20-Day Average Volume | 205 | 1,456,215 | 2,287,880 | ||
| Previous | 278.5000 | 202.95 | 205.52 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 277.9430 | 202.43 | 274.60 | ||
| 20-Day Raw Stochastic | 62.22% | 48.50% | 12.36% | ||
| 20-Day Relative Strength | 50.53 | 50.14 | 33.31 | ||
| Weighted Alpha | +62.70 | +46.91 | -51.71 | ||
| Today's Opinion | N/A | 80% Buy | 100% Sell | ||
| Yesterday's Opinion | N/A | 96% Buy | 100% Sell | ||
| Last Month's Opinion | N/A | 100% Buy | 48% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.89% since 10/27/17 | +0.84% since 07/27/26 | -20.86% since 07/27/26 | ||
| Low | 278.3400 on 11/06/17 | 199.40 on 07/28/26 | 197.81 on 07/30/26 | ||
| High | 280.0000 on 11/06/17 | 218.59 on 07/29/26 | 290.60 on 07/29/26 | ||
| 1-Month | |||||
| %Chg | +0.67% since 10/06/17 | -6.62% since 07/02/26 | -29.56% since 07/02/26 | ||
| Low | 276.0300 on 10/27/17 | 186.02 on 07/15/26 | 197.81 on 07/30/26 | ||
| High | 280.0000 on 11/06/17 | 218.59 on 07/29/26 | 380.00 on 07/09/26 | ||
| 3-Month | |||||
| %Chg | +0.29% since 08/04/17 | +7.89% since 05/01/26 | -25.59% since 05/01/26 | ||
| Low | 276.0300 on 10/27/17 | 184.90 on 06/02/26 | 197.81 on 07/30/26 | ||
| High | 280.0000 on 11/06/17 | 219.72 on 06/29/26 | 380.00 on 07/09/26 | ||
| 6-Month | |||||
| %Chg | +0.67% since 05/05/17 | +14.18% since 02/03/26 | -37.37% since 02/03/26 | ||
| Low | 273.5000 on 06/14/17 | 168.64 on 04/06/26 | 197.81 on 07/30/26 | ||
| High | 285.0500 on 05/25/17 | 219.72 on 06/29/26 | 380.00 on 07/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 29,891,406 | 29,986,670 | 27,439,592 | ||
| Shares Outstanding, K | 107,330 | 147,754 | 133,513 | ||
| Annual Sales, $M | 2,454,930,000 | 9,890,600,000 | 3,713,940,000 | ||
| Annual Net Income, $M | 707,040,000 | 1,292,900,000 | 313,750,000 | ||
| Last Qtr Sales, $M | N/A | 2,477,800,000 | 1,167,180,000 | ||
| Last Qtr Income, $M | N/A | 319,500,000 | 205,990,000 | ||
| 60-Month Beta | 1.54 | 0.16 | 0.27 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.60 on 07/29/26 | 1.84 on 07/30/26 | ||
| Latest Earnings Date | 01/01/70 | 10/29/26 | 10/29/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 35.21 | 14.88 | 38.19 | ||